Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)

Name: Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)
License: Public Domain

Diwakar Davar

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nsclc

nsclc, metastatic colorectal carcinoma, refractory melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143558
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.